Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trial

  • Joon Young Song
  • , Won Suk Choi
  • , Jung Yeon Heo
  • , Jin Soo Lee
  • , Dong Sik Jung
  • , Shin Woo Kim
  • , Kyung Hwa Park
  • , Joong Sik Eom
  • , Su Jin Jeong
  • , Jacob Lee
  • , Ki Tae Kwon
  • , Hee Jung Choi
  • , Jang Wook Sohn
  • , Young Keun Kim
  • , Ji Yun Noh
  • , Woo Joo Kim
  • , François Roman
  • , Maria Angeles Ceregido
  • , Francesca Solmi
  • , Agathe Philippot
    • Alexandra C. Walls, Lauren Carter, David Veesler, Neil P. King, Hun Kim, Ji Hwa Ryu, Su Jeen Lee, Yong Wook Park, Ho Keun Park, Hee Jin Cheong

Research output: Contribution to journal › Article › peer-review

76 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trial'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science